Harper Molly sold CPRX
December 12, 2025 · Form 4 insider transaction
Harper Molly sold 15,527 shares of Catalyst Pharmaceuticals Inc at $23.20 per share, a transaction worth $360.2K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
15,527
Price
$23.20
Total value
$360.2K
InsiderHarper Molly
Role—
SecurityCommon stock, par value $0.001 per share
Transaction codeS: Open-market sale
Transaction dateDecember 12, 2025
Filing dateDecember 16, 2025
Shares owned after13,579
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company.; Represents a weighted average price for the shares sold. Shares were sold in a range between $22.67 and $23.67 per share.